These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1012 related articles for article (PubMed ID: 35747790)
1. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y Front Oncol; 2022; 12():876660. PubMed ID: 35747790 [TBL] [Abstract][Full Text] [Related]
2. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
3. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
4. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y Front Immunol; 2022; 13():1038927. PubMed ID: 36451813 [TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma. Xu M; Mu J; Wang J; Zhou Q; Wang J Front Oncol; 2022; 12():961213. PubMed ID: 35965536 [TBL] [Abstract][Full Text] [Related]
6. A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma. Fu X; Duanmu J; Li T; Jiang Q PeerJ; 2020; 8():e8877. PubMed ID: 32309045 [TBL] [Abstract][Full Text] [Related]
7. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma. Tan Y; Lu L; Liang X; Chen Y World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the m6A-related lncRNA signature in predicting prognosis and immune response in patients with colon cancer. Chen S; Li X; Guo L; Zhang J; Li L; Wang X; Zhu Y; Wang J J BUON; 2021; 26(5):1931-1941. PubMed ID: 34761602 [TBL] [Abstract][Full Text] [Related]
9. A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma. Yang S; Zhou J; Chen Z; Sun Q; Zhang D; Feng Y; Wang X; Sun Y Front Oncol; 2022; 12():934928. PubMed ID: 35992788 [TBL] [Abstract][Full Text] [Related]
10. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma. Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J Front Immunol; 2022; 13():881359. PubMed ID: 35911752 [TBL] [Abstract][Full Text] [Related]
11. Metabolism-related lncRNAs signature to predict the prognosis of colon adenocarcinoma. Sun Y; Liu B; Xiao B; Jiang X; Xiang JJ; Xie J; Hu XM Cancer Med; 2023 Mar; 12(5):5994-6008. PubMed ID: 36366731 [TBL] [Abstract][Full Text] [Related]
12. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction. Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859 [TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis. Qian D; Qian C; Ye B; Xu M; Wu D; Li J; Li D; Yu B; Tao Y Front Genet; 2022; 13():760514. PubMed ID: 35273635 [No Abstract] [Full Text] [Related]
14. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration. Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R Front Immunol; 2022; 13():854785. PubMed ID: 35392086 [TBL] [Abstract][Full Text] [Related]
15. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related]
16. Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma. Zhang J; Wu Y; Mu J; Xin D; Wang L; Fan Y; Zhang S; Xu Y Front Oncol; 2022; 12():954226. PubMed ID: 36203430 [TBL] [Abstract][Full Text] [Related]
17. Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer. Dong X; Liao P; Liu X; Yang Z; Wang Y; Zhong W; Wang B Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629096 [TBL] [Abstract][Full Text] [Related]
18. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma. Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A Front Oncol; 2022; 12():941156. PubMed ID: 36505813 [TBL] [Abstract][Full Text] [Related]
19. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. Wang H; Wang W; Wang Z; Li X Front Immunol; 2023; 14():1291859. PubMed ID: 38143740 [TBL] [Abstract][Full Text] [Related]
20. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma. Guo Y; Wang Z; Tian Y; Li L; Dong J Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]